Article
APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells
20 Nov 2019
Abstract excerpt
Chemoresistance is one of the leading causes of cancer-related deaths in the United States. Triple negative breast cancer (TNBC), a subtype lacking the known breast cancer receptors used for targeted therapy, is reliant on chemotherapy as the standard of care. The Adenomatous Polyposis Coli ( APC ) tumor suppressor is mutated or hypermethylated in 70% of sporadic breast cancers with APC-deficient tumors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
